Atlas Trials

RBL001/RBL002 Phase I Clinical Trial

Clinical trial NCT01684241 · COMPLETED

Trial details

NCT number
NCT01684241
Sponsor
BioNTech RNA Pharmaceuticals GmbH
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Melanoma
Start date
2012-06-01
Primary completion
2015-05-01
Enrollment
29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.